WO2000019207A3 - Verfahren zur bestimmung von atrialem natriuretischem peptid (anp) - Google Patents

Verfahren zur bestimmung von atrialem natriuretischem peptid (anp) Download PDF

Info

Publication number
WO2000019207A3
WO2000019207A3 PCT/AT1999/000230 AT9900230W WO0019207A3 WO 2000019207 A3 WO2000019207 A3 WO 2000019207A3 AT 9900230 W AT9900230 W AT 9900230W WO 0019207 A3 WO0019207 A3 WO 0019207A3
Authority
WO
WIPO (PCT)
Prior art keywords
anp
natriuretic peptide
atrial natriuretic
identifying atrial
identifying
Prior art date
Application number
PCT/AT1999/000230
Other languages
English (en)
French (fr)
Other versions
WO2000019207A2 (de
Inventor
Wolfgang Woloszczuk
Albert Missbichler
Original Assignee
Biomedica Ges Mbh
Wolfgang Woloszczuk
Albert Missbichler
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biomedica Ges Mbh, Wolfgang Woloszczuk, Albert Missbichler filed Critical Biomedica Ges Mbh
Priority to AU60669/99A priority Critical patent/AU6066999A/en
Publication of WO2000019207A2 publication Critical patent/WO2000019207A2/de
Publication of WO2000019207A3 publication Critical patent/WO2000019207A3/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/575—Hormones
    • G01N2333/58—Atrial natriuretic factor complex; Atriopeptin; Atrial natriuretic peptide [ANP]; Brain natriuretic peptide [BNP, proBNP]; Cardionatrin; Cardiodilatin

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Endocrinology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Die Erfindung bezieht sich auf ein Verfahren zur Bestimmung von Atrialem Natriuretischem Peptid (ANP), wobei polyklonale Antikörper gegen Epitope des pro ANP (1-98) eingesetzt werden, die als Immunogene 1, 2 und 3 (SEQ.ID.Nr. 1, 2 und 3) definiert sind, und die diese Immunogene sowie rekombinantes pro ANP (1-98) spezifisch binden.
PCT/AT1999/000230 1998-09-29 1999-09-28 Verfahren zur bestimmung von atrialem natriuretischem peptid (anp) WO2000019207A2 (de)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU60669/99A AU6066999A (en) 1998-09-29 1999-09-28 Method for identifying atrial natriuretic peptide (anp)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AT161898A AT407674B (de) 1998-09-29 1998-09-29 Verfahren zur bestimmung von atrialem natriuretischem peptid (anp)
ATA1618/98 1998-09-29

Publications (2)

Publication Number Publication Date
WO2000019207A2 WO2000019207A2 (de) 2000-04-06
WO2000019207A3 true WO2000019207A3 (de) 2000-06-08

Family

ID=3517316

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/AT1999/000230 WO2000019207A2 (de) 1998-09-29 1999-09-28 Verfahren zur bestimmung von atrialem natriuretischem peptid (anp)

Country Status (3)

Country Link
AT (1) AT407674B (de)
AU (1) AU6066999A (de)
WO (1) WO2000019207A2 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2271674T3 (es) * 2002-11-20 2007-04-16 B.R.A.H.M.S Aktiengesellschaft Inmunoensayo tipo sandwich para la determinacion de peptidos parciales proanp.
GB2403533A (en) 2003-06-30 2005-01-05 Orion Corp Atrial natriuretic peptide and brain natriuretic peptide and assays and uses thereof
DE102007022367A1 (de) * 2007-05-07 2008-11-20 B.R.A.H.M.S Ag Verfahren zur Bestimmung von aminoterminalen pro-ANP bei übergewichtigen Patienten
JP2014210761A (ja) * 2013-04-05 2014-11-13 株式会社シバヤギ 抗イヌｎ末端プロ心房性ナトリウム利尿ペプチド抗体ならびにそれを用いた免疫学的測定方法、および免疫学的測定用キット

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1985002850A1 (en) * 1983-12-24 1985-07-04 Organogen Medizinisch-Molekularbiologische Forschu Cardiodilatine, a new peptide hormone and production process thereof
EP0173384A2 (de) * 1984-08-24 1986-03-05 Shionogi & Co., Ltd. Polypeptid verwandt mit alpha-hANP
EP0540021A1 (de) * 1991-10-31 1993-05-05 Mitsubishi Chemical Corporation Radioimmunologisches Untersuchungsverfahren
US5691310A (en) * 1987-09-29 1997-11-25 Vesely; David L. Methods of treatment using proANF peptides
US5786163A (en) * 1992-06-03 1998-07-28 Medinnova Sf BNP antibody and immunoassay using it

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1335082C (en) * 1987-09-01 1995-04-04 Hiroo Imura Monoclonal antibody recognizing –-hanp and a reagent for immunoassay of –-hanp
JP2681370B2 (ja) * 1988-06-30 1997-11-26 塩野義製薬株式会社 免疫測定法
JP2561513B2 (ja) * 1988-07-04 1996-12-11 塩野義製薬株式会社 γ−ＡＮＰを認識するモノクローナル抗体
JP2873586B2 (ja) * 1988-07-15 1999-03-24 武田薬品工業株式会社 抗体およびこれを用いる免疫化学的測定方法
JPH0667319B2 (ja) * 1989-04-19 1994-08-31 塩野義製薬株式会社 Ａｎｐのｃ端側を認識するモノクローナル抗体
JPH0748071B2 (ja) * 1989-05-31 1995-05-24 株式会社ミドリ十字 ｈＡＮＰ抗体及びｈＡＮＰの免疫学的測定法

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1985002850A1 (en) * 1983-12-24 1985-07-04 Organogen Medizinisch-Molekularbiologische Forschu Cardiodilatine, a new peptide hormone and production process thereof
EP0173384A2 (de) * 1984-08-24 1986-03-05 Shionogi & Co., Ltd. Polypeptid verwandt mit alpha-hANP
US5691310A (en) * 1987-09-29 1997-11-25 Vesely; David L. Methods of treatment using proANF peptides
EP0540021A1 (de) * 1991-10-31 1993-05-05 Mitsubishi Chemical Corporation Radioimmunologisches Untersuchungsverfahren
US5786163A (en) * 1992-06-03 1998-07-28 Medinnova Sf BNP antibody and immunoassay using it

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
MACAULAY HUNTER E F ET AL: "Analysis of peptides derived from Pro Atrial Natriuretic Peptide that circulate in man and increase in heart disease.", SCANDINAVIAN JOURNAL OF CLINICAL AND LABORATORY INVESTIGATION, (1998 MAY) 58 (3) 205-16., XP000892355 *
NUMATA, YOSHITO ET AL: "Immunoradiometric assay for the N-terminal fragment of proatrial natriuretic peptide in human plasma", CLIN. CHEM. (WASHINGTON, D. C.) (1998), 44(5), 1008-1013, XP000877463 *
VESELY D L ET AL: "Negative feedback of atrial natriuretic peptides.", JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM, (1994 MAY) 78 (5) 1128-34., XP000892356 *

Also Published As

Publication number Publication date
AU6066999A (en) 2000-04-17
AT407674B (de) 2001-05-25
WO2000019207A2 (de) 2000-04-06
ATA161898A (de) 2000-09-15

Similar Documents

Publication Publication Date Title
IL163066A (en) Ligands for the zcytor17 receptor
WO1999047656A3 (en) Nucleic acid binding proteins
WO2005087811A3 (en) Estrogen receptors and methods of use
HK1142272A1 (en) Specific binding proteins and uses thereof
WO2005051998A3 (en) Antibodies binding to a c-terminal fragment of apolipoprotein e
EP0823486A3 (de) Verfahren zur Hemmung der Bindung von DNA-Bindungsproteinen mit Duplex-DNA
HK1050695A1 (en) Methods for generating human monoclonal antibodies
WO2001070984A3 (en) Anti-tissue factor antibodies with enhanced anticoagulant potency
EP1176195A4 (de) VERFAHREN ZUR KONTROLLE DER AKTIVITäT VON IMMUNOLOGISCH FUNKTIONELLEM MOLEKüL
IL144062A0 (en) METHOD OF IDENTIFYING N-TERMINAL proBNP
WO2003087129A3 (en) Immunogenic peptides, and method of identifying same
WO1999003987A3 (fr) Epitopes du vrs et anticorps les comportant, utiles dans le diagnostic et la therapie
WO1996012809A3 (fr) Sequences nucleotidiques d'antigenes retroviraux vih-1 groupe (ou sous-groupe) o
DK1114156T3 (da) Transformerende vækstfaktor Beta-9 (ZTGFSS9) fra pattedyr
WO2003046205A3 (en) Methods for identifying modulators of apoptosis
WO2000019207A3 (de) Verfahren zur bestimmung von atrialem natriuretischem peptid (anp)
WO2000050607A3 (en) Goodpasture antigen binding protein
WO2000053742A3 (en) Polynucleotides and proteins encoded thereby
EP0931834A3 (de) Echinocandin-bindungsdomäne von 1,3-Beta-glukan Synthase
EP0933427A3 (de) Beta-Carotinhydroxylase Gen
WO2002033084A3 (en) Identification of the dombrock blood group glycoprotein as a polymorphic member of the adp-ribosyltransferase gene family
WO2000023477A3 (en) Immunoglobulin variants
WO2000037492A3 (en) Human hepatoma-derived growth factor homologous (huhdgfh) ____
WO2003027150A1 (fr) Anticorps et son utilisation
NZ505866A (en) V196 (also known as RAMP2) DNA and polypeptides

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AU CA JP NO US

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE

121 Ep: the epo has been informed by wipo that ep was designated in this application
AK Designated states

Kind code of ref document: A3

Designated state(s): AU CA JP NO US

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
NENP Non-entry into the national phase

Ref country code: CA

122 Ep: pct application non-entry in european phase